Daryl C Pope

Array ( [id] => 4350118 [patent_doc_number] => 06214824 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Use of amiloride for treating cancer' [patent_app_type] => 1 [patent_app_number] => 9/370643 [patent_app_country] => US [patent_app_date] => 1999-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3096 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214824.pdf [firstpage_image] =>[orig_patent_app_number] => 370643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410072 [patent_doc_number] => 06300349 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Inhibition of tumor necrosis factor alpha' [patent_app_type] => 1 [patent_app_number] => 9/364562 [patent_app_country] => US [patent_app_date] => 1999-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14464 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 256 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300349.pdf [firstpage_image] =>[orig_patent_app_number] => 364562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4303932 [patent_doc_number] => 06251870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Pharmaceutical composition for inhibiting growth of cancers' [patent_app_type] => 1 [patent_app_number] => 9/364021 [patent_app_country] => US [patent_app_date] => 1999-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3105 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251870.pdf [firstpage_image] =>[orig_patent_app_number] => 364021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4331823 [patent_doc_number] => 06313178 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Use of hexahydrolupulones as antibacterial and anticancer agents' [patent_app_type] => 1 [patent_app_number] => 9/125928 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6481 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/313/06313178.pdf [firstpage_image] =>[orig_patent_app_number] => 125928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1578891 [patent_doc_number] => 06448287 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Treatment of cancer using lipoic acid in combination with ascorbic acid' [patent_app_type] => B1 [patent_app_number] => 09/359498 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4118 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448287.pdf [firstpage_image] =>[orig_patent_app_number] => 09359498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1393851 [patent_doc_number] => 06545034 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Use of etodolac for the treatment of chronic lymphocytic leukemia' [patent_app_type] => B1 [patent_app_number] => 09/360020 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 4533 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/545/06545034.pdf [firstpage_image] =>[orig_patent_app_number] => 09360020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586423 [patent_doc_number] => 06359000 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Anticancer agent' [patent_app_type] => B1 [patent_app_number] => 09/352320 [patent_app_country] => US [patent_app_date] => 1999-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5285 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359000.pdf [firstpage_image] =>[orig_patent_app_number] => 09352320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328656 [patent_doc_number] => 06319904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Formulation comprising antibacterial substance and antiulcer substance' [patent_app_type] => 1 [patent_app_number] => 9/348313 [patent_app_country] => US [patent_app_date] => 1999-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11264 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319904.pdf [firstpage_image] =>[orig_patent_app_number] => 348313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470173 [patent_doc_number] => 06407075 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Fatty acid treatment' [patent_app_type] => B1 [patent_app_number] => 09/254286 [patent_app_country] => US [patent_app_date] => 1999-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2519 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407075.pdf [firstpage_image] =>[orig_patent_app_number] => 09254286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4294573 [patent_doc_number] => 06180633 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Drug resistance and multidrug resistance modulators' [patent_app_type] => 1 [patent_app_number] => 9/345255 [patent_app_country] => US [patent_app_date] => 1999-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8748 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180633.pdf [firstpage_image] =>[orig_patent_app_number] => 345255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4346775 [patent_doc_number] => 06284784 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Substituted 2-pyrrolidinone activators of PKC' [patent_app_type] => 1 [patent_app_number] => 9/339072 [patent_app_country] => US [patent_app_date] => 1999-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18678 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 544 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284784.pdf [firstpage_image] =>[orig_patent_app_number] => 339072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4346248 [patent_doc_number] => 06284751 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Therapeutic treatment for VEGF related diseases' [patent_app_type] => 1 [patent_app_number] => 9/335887 [patent_app_country] => US [patent_app_date] => 1999-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7492 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 333 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284751.pdf [firstpage_image] =>[orig_patent_app_number] => 335887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190863 [patent_doc_number] => 06153643 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Anti-cancer-substance' [patent_app_type] => 1 [patent_app_number] => 9/336481 [patent_app_country] => US [patent_app_date] => 1999-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 861 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153643.pdf [firstpage_image] =>[orig_patent_app_number] => 336481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1348266 [patent_doc_number] => 06579857 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/330905 [patent_app_country] => US [patent_app_date] => 1999-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8799 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579857.pdf [firstpage_image] =>[orig_patent_app_number] => 09330905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4183243 [patent_doc_number] => 06020361 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Substituted benzo[1,4]dioxines as antiobesity agents' [patent_app_type] => 1 [patent_app_number] => 9/323463 [patent_app_country] => US [patent_app_date] => 1999-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4847 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 292 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020361.pdf [firstpage_image] =>[orig_patent_app_number] => 323463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356654 [patent_doc_number] => 06218434 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Use of the naturally-occurring quinones thymoquinone and dithymoquinone as antineoplastic and cytotoxic agents' [patent_app_type] => 1 [patent_app_number] => 9/321832 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4216 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218434.pdf [firstpage_image] =>[orig_patent_app_number] => 321832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272328 [patent_doc_number] => 06245789 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'HIV and viral treatment' [patent_app_type] => 1 [patent_app_number] => 9/312949 [patent_app_country] => US [patent_app_date] => 1999-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6685 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245789.pdf [firstpage_image] =>[orig_patent_app_number] => 312949 [rel_patent_id] =>[rel_patent_doc_number] =>)